Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer related mortality and morbidity in the United States and worldwide. The advent of Immunotherapy has significantly improved lung cancer prognosis. However, there is a huge unmet need for novel agents, as a significant number of patients do no...

Descripción completa

Detalles Bibliográficos
Autores principales: Katiyar, Vatsala, Chesney, Jason, Kloecker, Goetz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377757/
https://www.ncbi.nlm.nih.gov/pubmed/37509394
http://dx.doi.org/10.3390/cancers15143733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377757/
https://www.ncbi.nlm.nih.gov/pubmed/37509394
http://dx.doi.org/10.3390/cancers15143733

Ejemplares similares